Alginate-encapsulated producer cells: A potential new approach for the treatment of malignant brain tumors

Cell Transplantation

Volumn 9, Issue 6, 2000, Pages 773-783

  Thorsen, F ^a   Read, T A ^a   Lund Johansen, M ^a   Tysnes, B B ^a   Bjerkvig, R ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brain tumors; Gene therapy; Producer cells; Sodium alginate

Indexed keywords

ALGINIC ACID; BETA GALACTOSIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BRAIN TUMOR; CANCER INHIBITION; CELL CYCLE; CELL LINE; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMBRYO; ENCAPSULATION; ENZYME SYNTHESIS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GRAFT REJECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0034485705     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970000900604     Document Type: Article

References (50)

1. Characteristics of human and rat glioma cells grown in a defined medium
2. Dietary effects of sodium alginate in humans
3. Gene therapy for cancer
4. Analysis of PCP data to determine the fraction of cells in the various phases of cell cycle
5. Tumor cell invasion and angiogenesis in the central nervous system
6. Immobilized plant cells
7. Microencapsulation of parathyroid cells as a bioartificial parathyroid
8. Genotypes and phenotypes of ten inbred strains of BD-rats
9. Mass transfer effects in microencapsulated hybridoma cells producing monoclonal antibodies
10. The involvement of CDI4 in stimulation of cytokine production by uronic acid polymers
11. Gene therapy using retroviral vectors
12. A new type porous carrier and its application to culture of suspension cells
13. Continuous production of monoclonal antibody by hybridoma cells immobilized in hardened alginate gel particles
14. Delivery of a secretable adenosine deaminase through microcapsules - A novel approach to somatic gene therapy
15. TNF production from peripheral blood mononuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide
16. Neoplastic transformation of fetal rat brain cells in culture after exposure to ethylnitrosourea in vivo
17. Immunotherapy with monoclonal antibodies directed against the immunosuppressive domain of p15E inhibits tumour growth
18. An evaluation of the local reaction and biodegradation of calcium sodium algihate (Kaltostat) following subcutaneous implantation in the rat
19. Microencapsulated islets as bioartificial endocrine pancreas
20. Expression of human factor IX by microencapsulated recombinant fibroblasts
21. Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture
22. Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads
23. Alginate as immobilization material: III Diffusional properties
24. Synthesis and secretion of protein by hepatocytes entrapped within calcium alginate
25. A basic study on the hybridoma cell culture of microencapsulation
26. Production of monoclonal antibodies against human chorionic gonadotropin by hybridoma cultures in calcium alginate capsules
27. Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane
28. Immunological studies of SK2 hybridoma cells microencapsulated with alginate-poly(L)lysine-alginate (APA) membrane following allogeneic transplantation
29. Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane
30. Induction of cytokine production from human monocytes stimulated with alginate
31. Cancer vaccines
32. Cells encapsulated in alginate: A potential system for delivery of recombinant proteins to malignant brain tumours
33. Modulation of systemic cytokine levels by implantation of alginate encapsulated cells
34. Immobilized cells: A review of recent literature
35. Calcium alginate immobilized hybridomas grown using a fluidized-bed perfusion system with a protein-free medium
36. Hybridoma cells in a protein-free medium within a composite gel perfusion bioreactor
37. Alginate as immobilization matrix for cells
38. Long-term reversal of diabetes by the injection of immunoprotected islets
39. Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets
40. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines
41. Microencapsulation of recombinant cells: A new delivery system for gene therapy
42. An experimental model of retrovirus gene therapy for malignant brain tumors
43. Experimental and clinical studies of cytokine gene-modified tumor cells
44. Release of replication-deficient retroviruses from a packaging cell line: Interaction with glioma tumor spheroids in vitro
45. Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene
46. Gene-modified cells for the treatment of cancer
47. A simplified method for production and growth of multicellular tumor spheroids
48. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype